Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Randomized discontinuation design: application to cytostatic antineoplastic agents.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Randomized discontinuation design: application to cytostatic antineoplastic agents.
Randomized discontinuation design: application to cytostatic antineoplastic agents. J Clin Oncol. 2002 Nov 15; 20(22):4478-84.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Renal Cell
Disease Progression
Double-Blind Method
Drug Administration Schedule
Humans
Kidney Neoplasms
Research Design
authors with profiles
Mark J. Ratain
Walter M. Stadler